Mannkind Invest Advisor

MannKind Advances Clinical Trials for NTM Lung Disease Treatment in Japan Sep 19, 2024

MannKind Corporation Secures Up To $200 Million In Royalty Agreement With Sagard Healthcare Jan 2, 2024